As antibody-drug conjugates aspire to advance to earlier-line treatments, harnessing innovation has never been more important to redefine the oncology standard of care and provide long-term benefit to patients.
Returning as the annual touchpoint for the global community, the 16th World ADC San Diego is THE week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit.
With 7 streams of end-to-end content spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop bioconjugate shop to bring your team up to speed with ADC fundamentals, get answers to the problems hindering your ADC R and D, and identify emerging trends to ensure you stay ahead of the curve.
Providing unparalleled networking opportunities with 1,400+ attendees from start-ups, biotechs, large pharma and leading service providers, anybody who is anybody in the ADC field will unite under one roof to innovate, collaborate, and redefine the standard of oncology care.
Returning as the annual touchpoint for the global community, the 16th World ADC San Diego is THE week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit.
With 7 streams of end-to-end content spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop bioconjugate shop to bring your team up to speed with ADC fundamentals, get answers to the problems hindering your ADC R and D, and identify emerging trends to ensure you stay ahead of the curve.
Providing unparalleled networking opportunities with 1,400+ attendees from start-ups, biotechs, large pharma and leading service providers, anybody who is anybody in the ADC field will unite under one roof to innovate, collaborate, and redefine the standard of oncology care.
